Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 1/2023

16-11-2022 | Endoscopic Retrograde Pancreatography | Case Report

Eosinophilic pancreatitis with serum IgG4-positivity, potentially associated with autoimmune pancreatitis

Authors: Shodai Takeda, Tatsunori Satoh, Shinya Kawaguchi, Shinya Endo, Shuzo Terada, Aya Muramatsu

Published in: Clinical Journal of Gastroenterology | Issue 1/2023

Login to get access

Abstract

A 70-year-old man presented with unprovoked weight loss and intermittent left upper quadrant tenderness for one-and-a-half month. Computed tomography revealed irregular cystic lesions in the pancreatic tail. Endoscopic ultrasonography (EUS) revealed pancreatic tail enlargement and giant, thick-walled cysts surrounding the pancreatic tail with no connection with the pancreatic duct. Endoscopic ultrasonography-guided fine-needle aspiration was performed on the enlarged pancreatic parenchyma and thickened cyst wall. Both biopsies showed hyper eosinophilia and few plasma cells. Endoscopic retrograde pancreatography revealed an irregular narrowing of the main pancreatic duct. Pancreatic juice cytology revealed substantial eosinophilia. Blood sampling showed an elevated eosinophil count and immunoglobulin G4 (IgG4) and immunoglobulin E (IgE) levels at the initial examination. We considered the patient to have eosinophilic pancreatitis (EP) with autoimmune pancreatitis, or alternately, EP with IgG4-related retroperitoneal fibrosis (RPF). Upon prednisolone administration, the abdominal pain improved, the peripheral blood eosinophil count decreased to zero, IgG4 and IgE levels decreased, pancreatic enlargement improved, and the cystic lesions disappeared. The condition did not recur within the following 3 years. Both EP and EP with IgG4-related RPF are rare etiologies of pancreatitis, and this case is very instructive.
Literature
1.
go back to reference Abraham SC, Leach S, Yeo CJ, et al. Eosinophilic pancreatitis and increased eosinophils in the pancreas. Am J Surg Pathol. 2003;27:334–42.CrossRef Abraham SC, Leach S, Yeo CJ, et al. Eosinophilic pancreatitis and increased eosinophils in the pancreas. Am J Surg Pathol. 2003;27:334–42.CrossRef
2.
go back to reference Manohar M, Verma A, Singh G, et al. Eosinophilic pancreatitis: a rare or unexplored disease entity. Gastroenterol Rev. 2020;15:34–8.CrossRef Manohar M, Verma A, Singh G, et al. Eosinophilic pancreatitis: a rare or unexplored disease entity. Gastroenterol Rev. 2020;15:34–8.CrossRef
3.
go back to reference Sun Y, Pan D, Kang K, et al. Eosinophilic pancreatitis: a review of the pathophysiology, diagnosis, and treatment. Gastroenterol Rep. 2021;9:115–24.CrossRef Sun Y, Pan D, Kang K, et al. Eosinophilic pancreatitis: a review of the pathophysiology, diagnosis, and treatment. Gastroenterol Rep. 2021;9:115–24.CrossRef
4.
go back to reference Barresi G, Inferrera C, De Luca F. Eosinophilic pancreatitis in the newborn infant of a diabetic mother. Virchows Arch A Pathol Anat Histol. 1978;380:341–8.CrossRef Barresi G, Inferrera C, De Luca F. Eosinophilic pancreatitis in the newborn infant of a diabetic mother. Virchows Arch A Pathol Anat Histol. 1978;380:341–8.CrossRef
5.
go back to reference John R, Yanchak T, Ramirez J. Eosinophilic pancreatitis presenting as possible malignancy. Proc (Bayl Univ Med Cent). 2021;34:510–1. John R, Yanchak T, Ramirez J. Eosinophilic pancreatitis presenting as possible malignancy. Proc (Bayl Univ Med Cent). 2021;34:510–1.
7.
go back to reference De Moura DTH, Rocha RSP, Jukemura J, et al. A rare non-oncological pancreatic mass: eosinophilic pancreatitis diagnosis through EUS-FNA. Endosc Int Open. 2019;7:E151–4.CrossRef De Moura DTH, Rocha RSP, Jukemura J, et al. A rare non-oncological pancreatic mass: eosinophilic pancreatitis diagnosis through EUS-FNA. Endosc Int Open. 2019;7:E151–4.CrossRef
8.
go back to reference Reppucci J, Chang M, Hughes S, et al. Eosinophilic pancreatitis: a rare cause of recurrent acute pancreatitis. Case Rep Gastroenterol. 2017;11:120–6.CrossRef Reppucci J, Chang M, Hughes S, et al. Eosinophilic pancreatitis: a rare cause of recurrent acute pancreatitis. Case Rep Gastroenterol. 2017;11:120–6.CrossRef
9.
go back to reference Tian L, Fu P, Dong X, et al. Eosinophilic pancreatitis: three case reports and literature review. Mol Clin Oncol. 2016;4:559–62.CrossRef Tian L, Fu P, Dong X, et al. Eosinophilic pancreatitis: three case reports and literature review. Mol Clin Oncol. 2016;4:559–62.CrossRef
10.
go back to reference Kakodkar S, Omar H, Cabrera J, et al. Eosinophilic pancreatitis diagnosed with endoscopic ultrasound. ACG Case Rep J. 2015;2:239–41.CrossRef Kakodkar S, Omar H, Cabrera J, et al. Eosinophilic pancreatitis diagnosed with endoscopic ultrasound. ACG Case Rep J. 2015;2:239–41.CrossRef
11.
go back to reference Yasuoka Y, Yoshida A, Nakajyou T, et al. A case report of eosinophilic pancreatitis presenting as inflammatory pancreatic tumor, in Japanese. Jpn Soc Gastroenterol Surg. 2008;41:1953–9.CrossRef Yasuoka Y, Yoshida A, Nakajyou T, et al. A case report of eosinophilic pancreatitis presenting as inflammatory pancreatic tumor, in Japanese. Jpn Soc Gastroenterol Surg. 2008;41:1953–9.CrossRef
12.
go back to reference Rakesh K, Banerjee R, Gupta R, et al. Eosinophilic pancreatitis with pseudocyst. Indian J Gastroenterol. 2007;26:136–7. Rakesh K, Banerjee R, Gupta R, et al. Eosinophilic pancreatitis with pseudocyst. Indian J Gastroenterol. 2007;26:136–7.
13.
go back to reference Stevens T, Mackey R, Falk GW, et al. Eosinophilic pancreatitis presenting as a pancreatic mass with obstructive jaundice. Gastrointenst Endosc. 2006;63:525–7.CrossRef Stevens T, Mackey R, Falk GW, et al. Eosinophilic pancreatitis presenting as a pancreatic mass with obstructive jaundice. Gastrointenst Endosc. 2006;63:525–7.CrossRef
14.
go back to reference Cay A, Imamoglu M, Cobanoglu U. Eosinophilic pancreatitis mimicking pancreatic neoplasia. Can J Gastroenterol. 2006;20:361–4.CrossRef Cay A, Imamoglu M, Cobanoglu U. Eosinophilic pancreatitis mimicking pancreatic neoplasia. Can J Gastroenterol. 2006;20:361–4.CrossRef
15.
go back to reference Le Connie D, Nguyen H. Eosinophilic gastroenteritis, ascites, and pancreatitis: a case report and review of the literature. South Med J. 2004;97:905–6.CrossRef Le Connie D, Nguyen H. Eosinophilic gastroenteritis, ascites, and pancreatitis: a case report and review of the literature. South Med J. 2004;97:905–6.CrossRef
16.
go back to reference Song JW, Kim MH, Seo WJ, et al. A case of eosinophilic pancreatitis. Korean J Gastroenterol. 2003;42:444–9. Song JW, Kim MH, Seo WJ, et al. A case of eosinophilic pancreatitis. Korean J Gastroenterol. 2003;42:444–9.
17.
go back to reference Euscher E, Vaswani K, Frankel W. Eosinophilic pancreatitis: a rare entity that can mimic a pancreatic neoplasm. Ann Diagn Pathol. 2000;4:379–85.CrossRef Euscher E, Vaswani K, Frankel W. Eosinophilic pancreatitis: a rare entity that can mimic a pancreatic neoplasm. Ann Diagn Pathol. 2000;4:379–85.CrossRef
18.
go back to reference Barthet M, Hastier P, Buckley MJ, et al. Eosinophilic pancreatitis mimicking pancreatic neoplasia: EUS and ERCP findings– is nonsurgical diagnosis possible. Pancreas. 1998;17:419–22.CrossRef Barthet M, Hastier P, Buckley MJ, et al. Eosinophilic pancreatitis mimicking pancreatic neoplasia: EUS and ERCP findings– is nonsurgical diagnosis possible. Pancreas. 1998;17:419–22.CrossRef
19.
go back to reference Bastid C, Sahel J, Choux R, et al. Eosinophilic pancreatotis. Pancreas. 1990;5:104–7.CrossRef Bastid C, Sahel J, Choux R, et al. Eosinophilic pancreatotis. Pancreas. 1990;5:104–7.CrossRef
20.
go back to reference Kawa S, Kamisawa T, Notohara K. Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2018: revision of Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2011. Pancreas. 2020;49:e13-14.CrossRef Kawa S, Kamisawa T, Notohara K. Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2018: revision of Japanese clinical diagnostic criteria for autoimmune pancreatitis, 2011. Pancreas. 2020;49:e13-14.CrossRef
21.
go back to reference Notohara K. Autoimmune pancreatitis from the viewpoint of pathology-including the mechanism of its development, in Japanese. Clin Gastroenterol. 2018;33:157–63. Notohara K. Autoimmune pancreatitis from the viewpoint of pathology-including the mechanism of its development, in Japanese. Clin Gastroenterol. 2018;33:157–63.
22.
go back to reference Hara A, Watanabe T, Minaga K, et al. Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease. World J Gastroenterol. 2021;27:2257–69.CrossRef Hara A, Watanabe T, Minaga K, et al. Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease. World J Gastroenterol. 2021;27:2257–69.CrossRef
23.
go back to reference Yokode M, Shiokawa M, Kodama Y, et al. Review of diagnostic biomarkers in autoimmune pancreatitis: where are we now? Diagnostics. 2021;11:770.CrossRef Yokode M, Shiokawa M, Kodama Y, et al. Review of diagnostic biomarkers in autoimmune pancreatitis: where are we now? Diagnostics. 2021;11:770.CrossRef
24.
go back to reference Nishimura T, Masaoka T, Suzuki H, et al. Autoimmune pancreatitis with pseudocysts. J Gastroenterol. 2004;39:1005–10.CrossRef Nishimura T, Masaoka T, Suzuki H, et al. Autoimmune pancreatitis with pseudocysts. J Gastroenterol. 2004;39:1005–10.CrossRef
25.
go back to reference Muraki T, Hamano H, Ochi Y, et al. Corticosteroid-responsive pancreatic cyst found in autoimmune pancreatitis. J Gastroenterol. 2005;40:761–6.CrossRef Muraki T, Hamano H, Ochi Y, et al. Corticosteroid-responsive pancreatic cyst found in autoimmune pancreatitis. J Gastroenterol. 2005;40:761–6.CrossRef
26.
go back to reference Kubota K, Fujita Y, Sato T, et al. Autoimmune pancreatitis associated with pancreatic cyst: how can we manage it? J Hepatobiliary Panceat Sci. 2014;21:902–10.CrossRef Kubota K, Fujita Y, Sato T, et al. Autoimmune pancreatitis associated with pancreatic cyst: how can we manage it? J Hepatobiliary Panceat Sci. 2014;21:902–10.CrossRef
27.
go back to reference Nao F, Tetsuhide I, Hisato I, et al. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol. 2013;19:35–41.CrossRef Nao F, Tetsuhide I, Hisato I, et al. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol. 2013;19:35–41.CrossRef
28.
go back to reference Khandelwal A, Inoue D, Takahashi N. Autoimmune pancreatitis: an update. Abdom Radiol. 2020;45:1359–70.CrossRef Khandelwal A, Inoue D, Takahashi N. Autoimmune pancreatitis: an update. Abdom Radiol. 2020;45:1359–70.CrossRef
29.
go back to reference Morgenstern S, Brook E, Rinawi F, et al. Tissue and peripheral eosinophilia as predictors for disease outcome in children with ulcerative colitis. Dig Liver Dis. 2017;49:170–4.CrossRef Morgenstern S, Brook E, Rinawi F, et al. Tissue and peripheral eosinophilia as predictors for disease outcome in children with ulcerative colitis. Dig Liver Dis. 2017;49:170–4.CrossRef
30.
go back to reference Zhao Z, Wang Y, Guan Z, et al. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases. Clin Exp Rheumatol. 2016;34:119–25. Zhao Z, Wang Y, Guan Z, et al. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases. Clin Exp Rheumatol. 2016;34:119–25.
Metadata
Title
Eosinophilic pancreatitis with serum IgG4-positivity, potentially associated with autoimmune pancreatitis
Authors
Shodai Takeda
Tatsunori Satoh
Shinya Kawaguchi
Shinya Endo
Shuzo Terada
Aya Muramatsu
Publication date
16-11-2022
Publisher
Springer Nature Singapore
Published in
Clinical Journal of Gastroenterology / Issue 1/2023
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-022-01732-3

Other articles of this Issue 1/2023

Clinical Journal of Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine